New eczema foam shows promise in phase 3 trial
NCT ID NCT07173478
First seen Nov 01, 2025 · Last updated May 13, 2026 · Updated 18 times
Summary
This study tests a medicated foam (1% OPA-15406) against a placebo foam in adults with mild-to-moderate atopic dermatitis (eczema). About 156 participants will apply the foam daily for 4 weeks. The goal is to see if the foam can clear or nearly clear skin symptoms like redness and itching better than the placebo.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATOPIC DERMATITIS (AD) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-••••
Locations
-
Mita Dermatology Clinic
Tokyo, Japan
Conditions
Explore the condition pages connected to this study.